Books

El debate sobre la exención de los derechos de propiedad intelectual en tiempos de pandemia
South Centre, CEIDIE, Ginebra, 2023
Autores: Alejandra Aoun, Juan Correa, Martín A. Cortese, Vanesa Lowenstein, Sandra C. Negro, Guillermo E. Vidaurreta
South Centre, CEIDIE, Ginebra, 2023
Autores: Alejandra Aoun, Juan Correa, Martín A. Cortese, Vanesa Lowenstein, Sandra C. Negro, Guillermo E. Vidaurreta

Vaccines, Medicines and COVID-19
How Can WHO Be Given a Stronger Voice?
Springer, 2022
Author: Germán Velásquez
How Can WHO Be Given a Stronger Voice?
Springer, 2022
Author: Germán Velásquez

Access to Medicines and Vaccines
Implementing Flexibilities Under Intellectual Property Law
Springer 2021
Editors: Carlos M. Correa and Reto M. Hilty
Implementing Flexibilities Under Intellectual Property Law
Springer 2021
Editors: Carlos M. Correa and Reto M. Hilty
Policy Briefs

Assessing the State of Play in the WHO Pandemic Instrument Negotiations
Policy Brief 121, 18 July 2023
Viviana Muñoz Tellez
Policy Brief 121, 18 July 2023
Viviana Muñoz Tellez

Hacia una Agencia Latinoamericana y del Caribe de Medicamentos (AMLAC)
Informe Sobre Políticas 120, 11 de Julio de 2022
Germán Velásquez
Informe Sobre Políticas 120, 11 de Julio de 2022
Germán Velásquez

Towards A Latin American and Caribbean Medicines Agency (AMLAC)
Policy Brief 120, 11 July 2023
Germán Velásquez
Policy Brief 120, 11 July 2023
Germán Velásquez
Research Papers

The Intersection Between Intellectual Property, Public Health and Access to Climate-Related Technologies
Research Paper 188, 7 December 2023
By Lívia Regina Batista
Research Paper 188, 7 December 2023
By Lívia Regina Batista

Patentamiento de anticuerpos monoclonales. El caso de Argentina
Documento de Investigación 186, 14 de noviembre de 2023
Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
Documento de Investigación 186, 14 de noviembre de 2023
Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini

Promoting Jordan’s Use of Compulsory Licensing During the Pandemic
Research Paper 184, 15 September 2023
By Laila Barqawi
Research Paper 184, 15 September 2023
By Laila Barqawi
SouthNews

Copyrights and Access to Knowledge in the Age of Artificial Intelligence: South Centre and Thailand’s Court of Appeals for Specialized Cases course for judges
SouthNews No. 467, 31 October 2023
Vitor Ido
SouthNews No. 467, 31 October 2023
Vitor Ido

How to balance competition policies and intellectual property in the pharmaceutical industry is part of debate co-organized by the South Centre and the Administrative Council for Economic Defense (CADE) in Brasília
SouthNews No. 466, 27 October 2023
Vitor Ido
SouthNews No. 466, 27 October 2023
Vitor Ido

Good Pharmaceutical Patent Examination Promotes Access to Medicines: South Centre Side Event to the 64th WIPO Assemblies
SouthNews No. 463, 29 September 2023
Vitor Ido
SouthNews No. 463, 29 September 2023
Vitor Ido
SouthViews

Competition Law and Intellectual Property: A Study Drawing from The Eli Lilly Case on ‘Sham Litigation’ in Brazil
SouthViews No. 240, 1 September 2022
By Pablo Leurquin
SouthViews No. 240, 1 September 2022
By Pablo Leurquin

Doha Twenty Years On – Has The Promise Been Betrayed?
SouthViews No. 238, 20 June 2022
By Yousuf Vawda and Bonginkosi Shozi
SouthViews No. 238, 20 June 2022
By Yousuf Vawda and Bonginkosi Shozi

The WTO TRIPS Waiver and Essential Security Rights in 2022
SouthViews No. 235, 10 March 2022
By Dr. Alexander Beyleveld
SouthViews No. 235, 10 March 2022
By Dr. Alexander Beyleveld
Training Papers

Propiedad intelectual y acceso a medicamentos: una introducción a cuestiones clave – algunos términos y conceptos básicos
Material de Capacitación 1, Junio 2021
Por Germán Velásquez
Material de Capacitación 1, Junio 2021
Por Germán Velásquez

Propriété Intellectuelle et Accès aux Médicaments : Une Introduction aux Grandes Problématiques – Quelques Termes et Concepts de Base
Documents de Formation 1, Août 2020
Par Germán Velásquez
Documents de Formation 1, Août 2020
Par Germán Velásquez

Intellectual Property and Access to Medicines: An Introduction to Key Issues – Some Basic Terms and Concepts
Training Paper 1, December 2019
Dr. Germán Velásquez
Training Paper 1, December 2019
Dr. Germán Velásquez
Statements

Colombia declara de interés público el uso de patente sobre Dolutegravir para incrementar el acceso a tratamiento a personas que viven con HIV
3 de octubre de 2023
South Centre Statement
3 de octubre de 2023
South Centre Statement